CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this ...
Q4 2025 Earnings Call October 1, 2025 8:00 AM EDTCompany ParticipantsCharlotte McLaughlin - Vice President of Investor ...